Bulls holding strong on VITROMXSTO:VITR
Despite several attemps from the bears to reach the 160 level, the bulls are stronly in control.
It got cheap in the process. Probably a good opportunity.
Risk 15%
−28.4SEK
−3.85 BSEK
3.51 BSEK
69.04 M
About VITROLIFE AB
Sector
Industry
CEO
Bronwyn Brophy
Website
Headquarters
Gothenburg
Employees (FY)
1.12 K
Founded
1989
ISIN
SE0011205202
FIGI
BBG000DMWXX2
Vitrolife AB engages in the development, manufacture, and sale of products and systems for the preparation, cultivation, and storage of human cells, tissue, and organs. Its products and services include oocyte retrieval needles, sperm processing, IVF media and oil, micromanipulation pipettes, labware, benchtop incubators, time-lapse systems, preimplantation genetic testing, cryopreservation, laser and imaging systems, and lab quality control systems. The firm operates through the following geographical segments: Europe, Middle East, and Africa (EMEA); North and South America; Japan and Pacific; and Asia. The company was founded in 1994 and is headquartered in Gothenburg, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of VITR is 168.0 SEK — it has decreased by 7.84% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange VITROLIFE AB stocks are traded under the ticker VITR.
VITROLIFE AB is going to release the next earnings report on Jul 17, 2024. Keep track of upcoming events with our Earnings Calendar.
VITR stock is 14.01% volatile and has beta coefficient of 1.38. Check out the list of the most volatile stocks — is VITROLIFE AB there?
One year price forecast for VITROLIFE AB has a max estimate of 265.0 SEK and a min estimate of 220.0 SEK.
VITR earnings for the last quarter are −30.86 SEK whereas the estimation was 0.90 SEK which accounts for −3.55 K% surprise. Estimated earnings for the next quarter are 0.93 SEK. See more details about VITROLIFE AB earnings.
VITROLIFE AB revenue for the last quarter amounts to 904.00 M SEK despite the estimated figure of 904.00 M SEK. In the next quarter revenue is expected to reach 874.72 M SEK.
Yes, you can track VITROLIFE AB financials in yearly and quarterly reports right on TradingView.
VITR stock has fallen by 8.15% compared to the previous week, the month change is a 13.40% fall, over the last year VITROLIFE AB has showed a 22.37% decrease.
VITR net income for the last quarter is −4.18 B SEK, while the quarter before that showed 122.00 M SEK of net income which accounts for −3.53 K% change. Track more VITROLIFE AB financial stats to get the full picture.
Today VITROLIFE AB has the market capitalization of 24.68 B, it has decreased by 2.66% over the last week.
Yes, VITR dividends are paid annually. The last dividend per share was 0.85 SEK. As of today, Dividend Yield (TTM)% is 0.47%. Tracking VITROLIFE AB dividends might help you take more informed decisions.
Like other stocks, VITR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VITROLIFE AB stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 1.12 K employees. See our rating of the largest employees — is VITROLIFE AB on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VITROLIFE AB technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VITROLIFE AB stock shows the sell signal. See more of VITROLIFE AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on VITROLIFE AB future price: according to them, VITR price has a max estimate of 265.00 SEK and a min estimate of 220.00 SEK. Read a more detailed VITROLIFE AB forecast: see what analysts think of VITROLIFE AB and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VITROLIFE AB EBITDA is 1.19 B SEK, and current EBITDA margin is 32.97%. See more stats in VITROLIFE AB financial statements.